跳至主要内容
临床试验/NCT02160912
NCT02160912已完成不适用

Non Interventional Study Regarding the Application of Ectoin Mund- & Rachenspray in Patients With Acute Laryngitis and/or Acute Pharyngitis

Bitop AG8 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Bitop AG
入组人数
95
试验地点
8
主要终点
Change in Pharyngitis symptom score evaluated by the physician

研究概览

简要总结

In this observational study insights regarding the tolerability and influence on the quality of life of the topical treatment Ectoin Mund- and Rachenspray compared to Emser Pastillen in patients with acute Pharyngitis/ Laryngitis under real life conditions shall be gained.

Patients are treated with Ectoin Mund- & Rachenspray 1% or Emser Pastillen according to the demands of the physician and the instructions for use.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
6 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with acute Laryngitis and/or Pharyngitis which are already treated with Ectoin Mund- & Rachenspray 1% or Emser Pastillen

排除标准

  • contraindications according to instructions for use

结局指标

主要结局

Change in Pharyngitis symptom score evaluated by the physician

时间窗: Visit 1, Visit 2 (after 3 days), Visite 3 (after 7 days)

Assessment of the symptoms of pharyngitis on a 4 point scale (none, mild, moderate strong): * swollen palatine tonsils * swollen lymph nodes in the throat * fever * cough

次要结局

  • Change in patient's general condition evaluated by the physician(Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days))
  • Change in Evaluation of the hoarseness(Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days))
  • Change in Dysphagia(Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days))
  • Change in efficacy evaluation by the physician(Visit 1, Visit 2 (after 3 days), Visit 3 (after 1 week))
  • Change in efficacy evaluation by the patient(Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days))
  • Change in Evaluation of the tolerability by the physician(Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days)))
  • Change in number and type of adverse events(Visit 2 (after 3 days) Visit 3 (after 7 days))
  • Change in Evaluation of the tolerability by the patient(Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days)))

研究者

发起方
Bitop AG
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验